Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019;8(1):1546-1549.
doi: 10.1080/22221751.2019.1681242.

Identification of multidrug-resistant Neisseria gonorrhoeae isolates with combined resistance to both ceftriaxone and azithromycin, China, 2017-2018

Affiliations

Identification of multidrug-resistant Neisseria gonorrhoeae isolates with combined resistance to both ceftriaxone and azithromycin, China, 2017-2018

Qianqin Yuan et al. Emerg Microbes Infect. 2019.

Abstract

The growing multidrug-resistant Neisseria gonorrhoeae is a serious global threat to gonococcal therapy. During 2017-2018, we identified a rare multidrug-resistant (ceftriaxone and azithromycin) strain (GC250) and four strains (GC185, GC195, GC196 and GC249) with both resistance to ceftriaxone and decreased susceptibility to azithromycin. All strains belonged to NG-STAR ST1143, including the mosaic penA-60.001, which is closely related to ceftriaxone resistance. The characterization of antimicrobial resistance (AMR) determinants and phylogenetic analysis showed these five strains were closely related to internationally spreading ceftriaxone-resistant N. gonorrhoeae FC428, but with higher azithromycin MIC. Findings here demonstrated that this clone not only initiated clonal expansion in China, but acquired azithromycin resistance.

Keywords: Neisseria gonorrhoeae; azithromycin; ceftriaxone; multidrug-resistant; phylogeny.

PubMed Disclaimer

Conflict of interest statement

No potential conflict of interest was reported by the authors.

Figures

Figure 1.
Figure 1.
Maximum-likelihood tree based on 14965 genome-wide SNP sites. Strains shaded in green are isolates characterized in this study. Circle and star represent the susceptibility to ceftiaxone and azithromycin respectively. The scale is in the units of mutations per site.

References

    1. Yin YP, Han Y, Dai XQ, et al. . Susceptibility of Neisseria gonorrhoeae to azithromycin and ceftriaxone in China: a retrospective study of national surveillance data from 2013 to 2016. PLoS Med. 2018 Feb;15(2):e1002499. doi: 10.1371/journal.pmed.1002499 - DOI - PMC - PubMed
    1. Report on global sexually transmitted infection surveillance, 2018 . Geneva: World Health Organization; 2018. Licence: CC BY-NC-SA 3.0 IGO.
    1. Golparian D, Rose L, Lynam A, et al. . Multidrug-resistant Neisseria gonorrhoeae isolate, belonging to the internationally spreading Japanese FC428 clone, with ceftriaxone resistance and intermediate resistance to azithromycin, Ireland, August 2018. Euro Surveill. 2018 Nov;23(47). doi: 10.2807/1560-7917.ES.2018.23.47.1800617 - DOI - PMC - PubMed
    1. Terkelsen D, Tolstrup J, Johnsen CH, et al. . Multidrug-resistant Neisseria gonorrhoeae infection with ceftriaxone resistance and intermediate resistance to azithromycin, Denmark, 2017. Euro Surveill. 2017 Oct;22(42). doi: 10.2807/1560-7917.ES.2017.22.42.17-00659 - DOI - PMC - PubMed
    1. Eyre DW, Sanderson ND, Lord E, et al. . Gonorrhoea treatment failure caused by a Neisseria gonorrhoeae strain with combined ceftriaxone and high-level azithromycin resistance, England, February 2018. Euro Surveill. 2018 Jul;23(27). doi: 10.2807/1560-7917.ES.2018.23.27.1800323 - DOI - PMC - PubMed